Skip to content

ROLE OF GUDUCHI(PROCESSED) ON EKA KUSTHA (PSORIASIS)

EFFECT OF GUDUCHI CHURNA KRIYA PREPARED WITH GUDUCHI SWARASA DERIVED BY TWO DIFFERENT METHODS ON EKA KUSTHA (PSORIASIS)

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2013/12/004213
Enrollment
50
Registered
2013-12-13
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Patients having signs and symptoms of EKA KUSTHA (Psoriasis)

Interventions

Intervention1: group A: SBGC1- with less duration of immersion: dosage: 6 gm per day in divided doses before meal. For local Application: Tila Taila Qs Duration :8 weeks Control Intervention1: Group B

Sponsors

Institute for Post Graduate Teaching and Research in Ayurveda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: •Patients having classical sign and symptoms of Eka Kustha •Age group of patients will be between 16-60 years.

Exclusion criteria

Exclusion criteria: •Life threatening medical and surgical emergencies. •Age below 16 and above 60 years •Known case of D.M with uncontrolled blood sugar level, AIDS, Malignancy, Immuno-compromised state etc.

Design outcomes

Primary

MeasureTime frame
â?¢Improvement in the signs and symptoms of the disease as per Ayurvedic texts. â?¢The obtained data will be statistically analyzed and presented along with explanatory notes, discussion and conclusion. Timepoint: 30 days

Secondary

MeasureTime frame
Improvement will be assessed on the basis of relief found in cardinal symptoms of disease Progress in the signs and symptoms based on the standard pattern will be applied before and after treatment.Timepoint: 30 days

Countries

India

Contacts

Public ContactDr Prashant Bedarkar

IPGT AND RA

drprashantbedarkar@gmail.com8128217370

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026